Biochemical and molecular studies to investigate the synergistic anticancer effect of a combination of phosphodiesterase 5 inhibitors and sorafenib against hepatocellular carcinoma

Abstract

newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced